Inspecs Group PLC (SPECI)

Currency in GBP
43.00
0.00(0.00%)
Closed·
SPECI Scorecard
Full Analysis
Net income is expected to grow this year
SPECI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
42.0044.00
52 wk Range
37.0062.25
Key Statistics
Bid/Ask
40.00 / 45.00
Prev. Close
43
Open
42.5
Day's Range
42-44
52 wk Range
37-62.25
Volume
116.18K
Average Volume (3m)
311.43K
1-Year Change
-22.52%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SPECI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
60.04
Upside
+39.64%
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Inspecs Group PLC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Neutral

Inspecs Group PLC Company Profile

INSPECS Group plc designs, produces, sells, markets, and distributes fashion eyewear, lenses, and OEM products in the United Kingdom, Europe, North America, South America, Asia, Africa, and Australia. It operates through Frames and Optics; Manufacturing; and Lenses segments. The company offers its products under the retail brands, such as Barbour, Barbour International, BUFFALO David Bitton, CAT, Free Country, Henri Lloyd, Hype, JOSEPH, Lamb, Liberty, Lyle & Scott, Marc O’Polo, MINI, O’Neill, SUPERDRY, RADLEY LONDON, TALBOT RUNHOF, Ted Baker, Temperley LONDON, and Victor Rolf; and in house brands under BOTANIQ, SAVILE ROW Titanium, SAVILE ROW, BRENDEL Eyewear, FREIGEIST, HUMPHREY’S eyewear, JOS ESCHENBACH, and TITANFLEX names. INSPECS Group plc was founded in 1988 and is based in Bath, the United Kingdom.

Compare SPECI to Peers and Sector

Metrics to compare
SPECI
Peers
Sector
Relationship
P/E Ratio
−9.7x−2.1x−0.5x
PEG Ratio
0.030.010.00
Price/Book
0.5x1.6x2.6x
Price / LTM Sales
0.2x3.8x3.2x
Upside (Analyst Target)
39.2%56.3%42.7%
Fair Value Upside
Unlock16.0%5.8%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 60.04
(+39.64% Upside)

Earnings

Latest Release
Apr 15, 2025
EPS / Forecast
-0.04 / --
Revenue / Forecast
95.21M / --
EPS Revisions
Last 90 days

SPECI Income Statement

People Also Watch

1,009.00
WISEa
-0.20%
9.75
HVO
-2.50%
15.87
OSCR
+7.96%
289.60
HOCM
+7.66%

FAQ

What Stock Exchange Does Inspecs Trade On?

Inspecs is listed and trades on the London Stock Exchange stock exchange.

What Is the Stock Symbol for Inspecs?

The stock symbol for Inspecs is "SPECI."

What Is the Inspecs Market Cap?

As of today, Inspecs market cap is 43.72M.

What Is Inspecs's Earnings Per Share (TTM)?

The Inspecs EPS (TTM) is -0.05.

When Is the Next Inspecs Earnings Date?

Inspecs will release its next earnings report on 03 Sept 2025.

From a Technical Analysis Perspective, Is SPECI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Inspecs Stock Split?

Inspecs has split 0 times.

How Many Employees Does Inspecs Have?

Inspecs has 1654 employees.

What is the current trading status of Inspecs (SPECI)?

As of 23 Jul 2025, Inspecs (SPECI) is trading at a price of 43.00, with a previous close of 43.00. The stock has fluctuated within a day range of 42.00 to 44.00, while its 52-week range spans from 37.00 to 62.25.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.